Novocure Ltd - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
NVCR Nasdaq 2836 https://www.novocure.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Novocure Ltd

How Many Insiders Sold NovoCure Limited (NASDAQ:NVCR) Shares? - Jan 23rd, 2019 9:38 am
Novocure Ltd (NVCR) CEO Asaf Danziger Sold $9 million of Shares - Jan 18th, 2019 4:15 pm
Tamarack Capital Management’s Return, AUM, and Holdings - Jan 11th, 2019 10:24 am
Novocure Announces Fourth Quarter and Full Year 2018 Operating Statistics, Preliminary Net Revenues and Provides Company Update - Jan 7th, 2019 2:05 pm
Stocks down in December for pharma firms in the Triangle - Dec 27th, 2018 7:23 am
Is NovoCure a Buy? - Dec 24th, 2018 7:44 am
Novocure to Participate in the 37th Annual J.P. Morgan Healthcare Conference - Dec 21st, 2018 5:30 am
What Kind Of Shareholder Owns Most NovoCure Limited (NASDAQ:NVCR) Stock? - Dec 17th, 2018 12:20 pm
Novocure and the AACR Announce Four Inaugural Research Grants to Promote and Support Innovative Research on Tumor Treating Fields - Dec 17th, 2018 5:30 am
Is NovoCure Limited (NVCR) A Good Stock To Buy? - Dec 16th, 2018 7:10 am
3 Top Medical Device Stocks to Buy Now - Dec 12th, 2018 9:49 am
Why Portola Pharmaceuticals’ Stock Price Is Plummeting Today - Dec 11th, 2018 12:04 pm
Recent Analysis Shows Moody's, Hershey, NovoCure, Mohawk Industries, La-Z-Boy, and Lockheed Martin Market Influences — Renewed Outlook, Key Drivers of Growth - Dec 7th, 2018 5:55 am
Sub-Group Analysis of Novocure’s EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology Demonstrating More Time on Optune® Predicted Increased Survival - Dec 6th, 2018 5:30 am
Novocure and Zai Lab Awarded Deal of the Year at 5th Annual BioCentury China Healthcare Summit in Shanghai, China - Nov 14th, 2018 5:30 am
3 Top Healthcare Stocks to Buy in November - Nov 13th, 2018 6:01 pm
Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology - Nov 13th, 2018 6:24 am
Novocure and Zai Lab to Host Investor Event - Nov 7th, 2018 2:00 pm
NovoCure Limited (NASDAQ:NVCR): Is Breakeven Near? - Nov 7th, 2018 10:25 am